Eva Prieschl-Grassauer
Founder at MARINOMED BIOTECH AG
Profile
Eva Prieschl-Grassauer is the founder and Chief Scientific Officer at Marinomed Biotech AG, which is founded in 2006.
She previously worked as Head-Laboratory at AUSTRIANOVA Biomanufacturing AG from 2002 to 2006, and as Head-Allergy Program at Novartis Austria GmbH.
She also worked as a Product Manager at Wyeth Pharmaceuticals BV in 2002 and as a Project Manager at Onepharma in 2006.
Dr. Prieschl-Grassauer holds a doctorate degree from the University of Vienna.
Eva Prieschl-Grassauer active positions
Companies | Position | Start |
---|---|---|
MARINOMED BIOTECH AG | Founder | 2005-12-31 |
Former positions of Eva Prieschl-Grassauer
Companies | Position | End |
---|---|---|
Onepharma | Corporate Officer/Principal | 2006-06-30 |
AUSTRIANOVA Biomanufacturing AG
AUSTRIANOVA Biomanufacturing AG BiotechnologyHealth Technology AUSTRIANOVA Biomanufacturing AG engages in the developmente of proprietary drug delivery technologies in orphan niche indications in oncology. It offers NovaCaps, which targets tumours in pancreatic cancer. The company was founded in 2001 and is headquartered in Vienna, Austria. | Corporate Officer/Principal | 2005-12-31 |
Wyeth Pharmaceuticals BV | Corporate Officer/Principal | 2002-09-30 |
Novartis Austria GmbH
Novartis Austria GmbH Pharmaceuticals: MajorHealth Technology Novartis Austria GmbH operates as a holding company, which engages in the development and production of pharmaceutical products. The company was founded on January 30, 2006 and is headquartered in Vienna, Austria. | Corporate Officer/Principal | - |
Training of Eva Prieschl-Grassauer
University of Vienna | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MARINOMED BIOTECH AG | Health Technology |
Private companies | 4 |
---|---|
AUSTRIANOVA Biomanufacturing AG
AUSTRIANOVA Biomanufacturing AG BiotechnologyHealth Technology AUSTRIANOVA Biomanufacturing AG engages in the developmente of proprietary drug delivery technologies in orphan niche indications in oncology. It offers NovaCaps, which targets tumours in pancreatic cancer. The company was founded in 2001 and is headquartered in Vienna, Austria. | Health Technology |
Novartis Austria GmbH
Novartis Austria GmbH Pharmaceuticals: MajorHealth Technology Novartis Austria GmbH operates as a holding company, which engages in the development and production of pharmaceutical products. The company was founded on January 30, 2006 and is headquartered in Vienna, Austria. | Health Technology |
Wyeth Pharmaceuticals BV | |
Onepharma |
- Stock Market
- Insiders
- Eva Prieschl-Grassauer